September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Vincent Rajkumar: Outcomes with quadruplet induction and risk adapted maintenance in myeloma
Sep 18, 2024, 13:33

Vincent Rajkumar: Outcomes with quadruplet induction and risk adapted maintenance in myeloma

Vincent Rajkumar shared an article by Nisha S. Joseph on X:

“Outcomes with quadruplet induction and risk adapted maintenance in myeloma. Major progress Dr. Nisha Joseph, Ajay Nooka, SagarLonial, Winship Cancer Institute of Emory University and Blood Cancer Journal.”

Quoting Nisha S. Joseph’s post:

Tittle: Quadruplet therapy for newly diagnosed myeloma: comparative analysis of sequential cohorts with triplet therapy lenalidomide, bortezomib and dexamethasone (RVd) versus daratumamab with RVD (DRVd) in transplant-eligible patients

Authors: Nisha S. Joseph, Jonathan L, Kaufman, Vilas A. Gupta, Craig C. Hofmeister, Madhav V. Dhodapkar, Lawrence H. Boise,  Sara M. DiCamillo, Danielle Roberts, Ajay K. Nooka and Sagar Lonial Vincent Rajkumar: Outcomes with quadruplet induction and risk adapted maintenance in myeloma

Source: Vincent Rajkumar/X

Vincent Rajkumar is a Professor of Medicine at the Mayo Clinic in Rochester, Minnesota, and Chair for the Mayo Clinic Myeloma, Amyloidosis, and Dysproteinemia Group.  He also chairs the Board of directors of  The International Myeloma Foundation and the Eastern Cooperative Oncology Group (ECOG) Myeloma Committee. His extensive contributions include over 230 peer-reviewed publications, predominantly focusing on multiple myeloma and related plasma cell disorders. Furthermore, Dr. Rajkumar is a Section Editor for multiple myeloma and related disorders for Leukemia and an Associate Editor for the Mayo Clinic Proceedings.